These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6393864)

  • 21. Inadequate prophylaxis of malaria with dapsone-pyrimethamine.
    Cook IF
    Med J Aust; 1985 Mar; 142(6):340-2. PubMed ID: 3883112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The activity in vitro of cycloguanil and pyrimethamine in combination against Plasmodium falciparum.
    Yeo AE; Rieckmann KH
    Trans R Soc Trop Med Hyg; 1992; 86(3):234. PubMed ID: 1412640
    [No Abstract]   [Full Text] [Related]  

  • 23. Antifolate studies. Activities of 40 potential antimalarial compounds against sensitive and chlorguanide triazine resistant strains of folate-requiring bacteria and Escherichia coli.
    Genther CS; Smith CS
    J Med Chem; 1977 Feb; 20(2):237-43. PubMed ID: 137981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the 2,4-diamino-6 substituted quinazolines. I. Antimalarial activities of 2,4-diamino-6-[(3,4-dichlorobenzyl)-nitrosoamino]-quinazoline (CI-679) as exhibited in rhesus monkeys infected with the Ro or Ro/PM strains of Plasmodium cynomolgi.
    Schmidt LH; Rossan RN
    Am J Trop Med Hyg; 1979 Sep; 28(5):781-92. PubMed ID: 114064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of drug-resistant malaria in man.
    Clyde DF
    Bull World Health Organ; 1974; 50(3-4):243-9. PubMed ID: 4613507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gametocytocidal and sporontocidal effects of antimalarial drugs on malaria parasites. II. Action of the folic reductase inhibitors, chlorguanide, and pyrimethamine against Plasmodium cynomolgi.
    Omar MS; Collins WE; Contacos PG
    Exp Parasitol; 1974 Oct; 36(2):167-77. PubMed ID: 4413531
    [No Abstract]   [Full Text] [Related]  

  • 27. Analogues of N-benzyloxydihydrotriazines: in vitro antimalarial activity against Plasmodium falciparum.
    Childs GE; Lambros C
    Ann Trop Med Parasitol; 1986 Apr; 80(2):177-81. PubMed ID: 3530157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro selection of Plasmodium falciparum lines resistant to dihydrofolate-reductase inhibitors and cross resistance studies.
    Bhasin VK; Nair L
    Jpn J Med Sci Biol; 1996 Feb; 49(1):1-14. PubMed ID: 8799803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cycloguanil and its parent compound proguanil demonstrate distinct activities against Plasmodium falciparum malaria parasites transformed with human dihydrofolate reductase.
    Fidock DA; Nomura T; Wellems TE
    Mol Pharmacol; 1998 Dec; 54(6):1140-7. PubMed ID: 9855645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
    Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
    P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homology modeling of wild type and pyrimethamine/cycloguanil-cross resistant mutant type Plasmodium falciparum dihydrofolate reductase. A model for antimalarial chemotherapy resistance.
    Santos-Filho OA; de Alencastro RB; Figueroa-Villar JD
    Biophys Chem; 2001 Jul; 91(3):305-17. PubMed ID: 11551441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of cycloguanil pamoate (CI-501) against a chlorguanide-resistant Chesson strain of Plasmodium vivax.
    Chin W; Lunn JS; Buxbaum J; Contacos PG
    Am J Trop Med Hyg; 1965 Nov; 14(6):922-4. PubMed ID: 5320455
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of sporontocidal compounds using Plasmodium falciparum gametocytes produced in vitro.
    Teklehaimanot A; Nguyen-Dinh P; Collins WE; Barber AM; Campbell CC
    Am J Trop Med Hyg; 1985 May; 34(3):429-34. PubMed ID: 3890574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood schizontocidal activity of WR 238605 (Tafenoquine) against Plasmodium cynomolgi and Plasmodium fragile infections in rhesus monkeys.
    Puri SK; Dutta GP
    Acta Trop; 2003 Apr; 86(1):35-40. PubMed ID: 12711101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasmodium falciparum and Plasmodium vivax infections in the owl monkey (Aotus trivirgatus). III. Methods employed in the search for new blood schizonticidal drugs.
    Schmidt LH
    Am J Trop Med Hyg; 1978 Jul; 27(4):718-37. PubMed ID: 99057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hospital and field traials of sulformethoxine with pyrimethamine against Malaysian strains of Plasmodium falciparum and P. vivax.
    Laing AB
    Med J Malaya; 1968 Sep; 23(1):5-19. PubMed ID: 4237560
    [No Abstract]   [Full Text] [Related]  

  • 37. The urinary excretion and the antimalarial activity of CI-501 (cycloguanil-pamoate, Camolar) against vivax and falciparum malaria.
    Contacos PG; Coatney GR; Lunn JS; Chin W
    Am J Trop Med Hyg; 1966 May; 15(3):281-6. PubMed ID: 5328125
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-relapse activity of mirincamycin in the Plasmodium cynomolgi sporozoite-infected Rhesus monkey model.
    Fracisco S; Teja-isavadharm P; Gettayacamin M; Berman J; Li Q; Melendez V; Saunders D; Xie L; Ohrt C
    Malar J; 2014 Oct; 13():409. PubMed ID: 25326032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Some pharmacological aspects of antimalarial drugs.
    Botha D
    S Afr Med J; 1974 Jun; 48(29):1263-5. PubMed ID: 4607434
    [No Abstract]   [Full Text] [Related]  

  • 40. Causal prophylactic efficacy of primaquine, tafenoquine, and atovaquone-proguanil against Plasmodium cynomolgi in a rhesus monkey model.
    DiTusa C; Kozar MP; Pybus B; Sousa J; Berman J; Gettayacamin M; Im-erbsin R; Tungtaeng A; Ohrt C
    J Parasitol; 2014 Oct; 100(5):671-3. PubMed ID: 24780070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.